Technical Analysis for PDLI - PDL BioPharma, Inc.
|Grade||Last Price||% Change||Price Change|
PDLI closed down 1.58 percent on Wednesday, January 16, 2019, on 55 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical PDLI trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 16||Outside Day||Range Expansion||0.00%|
|Jan 16||Overbought Stochastic||Strength||0.00%|
|Jan 15||Overbought Stochastic||Strength||-1.58%|
|Jan 14||NR7||Range Contraction||-0.32%|
|Jan 14||Overbought Stochastic||Strength||-0.32%|
|Jan 11||Overbought Stochastic||Strength||-2.51%|
|Jan 10||New Uptrend||Bullish||-2.51%|
|Jan 10||New 52 Week High||Strength||-2.51%|
|Jan 10||Overbought Stochastic||Strength||-2.51%|
|Jan 9||New 52 Week Closing High||Bullish||-2.51%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more PDLI news...
|52 Week High||3.22|
|52 Week Low||2.25|
|200-Day Moving Average||2.6878|
|50-Day Moving Average||2.923|
|20-Day Moving Average||2.938|
|10-Day Moving Average||3.116|
|Average True Range||0.1207|
|Chandelier Exit (Long, 3 ATRs )||2.8579|
|Chandelier Exit (Short, 3 ATRs )||2.9021|
|Upper Bollinger Band||3.3439|
|Lower Bollinger Band||2.5321|
|Percent B (%b)||0.71|
|MACD Signal Line||0.0617|
|Market Cap||479.18 Million|
|Num Shares||154 Million|
|Price-to-Earnings (P/E) Ratio||7.07|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||3.29|
|Resistance 3 (R3)||3.30||3.26||3.26|
|Resistance 2 (R2)||3.26||3.21||3.25||3.25|
|Resistance 1 (R1)||3.18||3.18||3.16||3.17||3.24|
|Support 1 (S1)||3.06||3.09||3.04||3.05||2.98|
|Support 2 (S2)||3.02||3.06||3.01||2.97|
|Support 3 (S3)||2.94||3.02||2.96|
|Support 4 (S4)||2.93|